ð¢ç¥å¥å·çå»åž«äŒã¯ã©ãã®å»åž«äŒãããæ©ããæ¬åœã®ããšãç¥ã£ãŠãã ãã! æ°åã³ãããŠã€ã«ã¹ææçã«ã€ããŠããšã®ã¡ãã»ãŒãžãåºããŸãããããã3æäžæ¬ã®äºã§ãããã®ã¡ãã»ãŒãžã¯ä»ã§ãçãåŸãŠããã®ã§ããã²èªãã§ããããããšæããå šææ²èŒããŸãã â¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïž
ð¢ç¥å¥å·çå»åž«äŒã¯ã©ãã®å»åž«äŒãããæ©ããæ¬åœã®ããšãç¥ã£ãŠãã ãã! æ°åã³ãããŠã€ã«ã¹ææçã«ã€ããŠããšã®ã¡ãã»ãŒãžãåºããŸãããããã3æäžæ¬ã®äºã§ãããã®ã¡ãã»ãŒãžã¯ä»ã§ãçãåŸãŠããã®ã§ããã²èªãã§ããããããšæããå
šææ²èŒããŸãã
â¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïž
ç¥å¥å·ã¯ã¯ã«ãŒãºè¹ã®ææè
3000人ãããããŠããŠããã¹ã¯ãé²è·æãäžè¶³ããŠããŸããããªã®ã«ãæ±äº¬éœç¥äºã®å°æ± çŸååãäžåœãž33äžçã®é²è·æãå¯ä»ããããšãèãããšãã¯ãæ±äº¬ã¯æ¥æ¬ãããªããšæããŸããããã®é²è·æããã¹ã¯ãããã°ãããšäœäººãå©ããããã®ã§ãããããã¯ãå°æ± çŸååã®è¡çºã¯èä»»åéãšããç¯çœªã ãšããããŸããéœã®è²¡ç£ãåæã«å¥œããªåœã«ãããŠããããããŸããããããªäžã§ããç¥å¥å·ã®å»åž«ãã¡ã¯èªè¡éã®ååãåŸãŠãSARS-CoV2ã®å°ã蟌ãã«æåããŸãããã§ãããŸã æªç¥ã®ãŠã€ã«ã¹ãããå¯èœæ§ããããããPCRæ€æ»ãç¶è¡ããã®ã§ãã6æ以éäŸçµŠãããŠãåœç£ã®PCRæ€æ»ãããã¯åœéœæ§1% åœé°æ§30%æªæºãªã®ã§SARS-CoV2ãèŠéããŸããã颚éªãã€ã³ãã«ãšã³ã¶ãã€ããŸããŸããã ãããç±ãå³ãå³èŠé害ãªã©ã®çç¶ããã£ãããPCRæ€æ»ãåããŠéœæ§ãªããã®åŸã®æ€æ»ã«é²ã¿ãäœã®ææçã確å®ãããŠäžãããPCRæ€æ»ã§ã¯ãã®ãŠã€ã«ã¹ãSARSãã€ã³ãã«ãšã³ã¶ã颚éªãå€å®ã§ããŸããã
â¬ïžã§ã¯ãå
šææç²ãèªã¿ãŸããã
ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»
ããªããã³ããéä¿¡ã
PCRæ€æ»ã®æ¬åœ
ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»
å»çé¢ä¿è
ã¯ããããã§ã«ææã®ã¹ãã¬ã¹ã®äžã§é£æ¥æŠã£ãŠããŸãããã®äžã§ãPCR æ€æ»ãäœãäœã§ãæ°å€ãããã¹ãã ãšãã人ãããŸãã
ããããªãããæ°åã³ãããŠã€ã«ã¹ã® PCR æ€æ»ã®æ床ã¯é«ã㊠70ïŒ
çšåºŠã§ãã
ã€ãŸãã30ïŒ
以äžã®äººã¯ææããŠããã®ã«ãé°æ§ããšå€å®ããããåœé°æ§ããšãªããŸããæ€æ»ãããæããææè
ãå¿
ãããããšãã決ããŠå¿ããªãã§ãã ããã
ã€ã³ãã«ãšã³ã¶ã«æ¯ã¹ãŠ çŸåã®äžïœããååã®äžãšãããããŠã€ã«ã¹ã®å°ãªãã¯ãæ€æ»çµæã®å€å®ãé£ããããŠããŸãã
ãšãã«æ©ã段éã§ã® PCR æ€æ»ãæ²»çéçšïŒ10æ¥ä»¥éïŒã§ã®ã¯ã決ããŠäžèœã§ã¯ãªãããšãç解ããŠãã ããã
æ²»ã£ããšæã£ãŠãåã³éœæ§ãšãªã人ãããŸããããã¯åã«ãè¿°ã¹ãŸãããé°æ§ãšå€æããŠãããŠã€ã«ã¹ã®éãå°ãªããã誀ã£ãŠé°æ§ãšããå€æãããŠããŸãå±éºæ§ãããã®ã§ãã
è€æ°åæ€æ»ããŠããé°æ§ã«ãªã£ãŠããŸãåœé°æ§ã®æ£è
ãããåºãŠããŠããŸãã®ã§ãã
ãããŠãäœèª¿ã«ãã£ãŠçç¶ãåã³åºçŸããŠåçãã€ãŸãçç¶ãåºãŠããŸãå¯èœæ§ãããã®ã§ãã
ãã£ããšãã©ã€ãã¹ã«ãŒæ¹åŒã®æ€æ»ãããã°ãããšãã人ãããŸãããã®ææã®éäžã§ãæè¢ã PPEïŒé²è·æã»äºé²è¡£ïŒãäžã€ã²ãšã€äº€æããŠããã®ã§ãããããããè€æ°ã®æ£è
ãããžå¯Ÿå¿ãããšãäºæ¬¡ææã®å¯èœæ§ãèããªããã°ãªããŸãããæ£ç¢ºã§æ¬¡ã®æ€æ»ã®äººã«äºæ¬¡ææã®å±éºæ§ãåã°ãªãããã«ããã«ã¯ãäžäººã®æ£è
ããã®æ€æ»ãçµãã£ããããã¹ãŠã®ãã¹ã¯ã»ãŽãŒã°ã«ã»PPEïŒé²è·æã»äºé²è¡£ïŒãªã©ããæ€æ»ããæ¬äººãæ
éã«å€åŽã觊ããªãããã«è±ãã§ãç Žæ£åŠåããªããã°ãªããŸããã
ãã¹ã¯ã»PPEïŒé²è·æã»äºé²è¡£ïŒãªã©å¿
é è£
åã絶察çã«äžè¶³ããäžãã©ãããã°ããã®ã§ããããã
次ã®æ£è
ããã«ææãããªãããã«ããããã«ãæ¶æ¯ã亀æã®ããã30 åä»¥äž 1 æéè¿ãå¿
èŠãšãªããŸãã
ãã¬ããªã©ã®ã¡ãã£ã¢ã«ç»å Žãã人ã¯ãæ¬åœã® PCR æ€æ»ã®å®æ
ãç¥ã£ãŠããã®ã§ããããããããŠãå°é家ãšãã人ã¯å®éã«ãã£ãããšãããã®ã§ããããã
â¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïž
åœç«ææç 究æã®æ€æ»ã¬ã€ãã©ã€ã³ã¯
ç
åäœæ€åºããã¥ã¢ã« 2019-nCoV Ver.2.9.1 https://www.niid.go.jp/niid/images/lab-manual/2019-nCoV20200319.pdf
â¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïž
è¡æ¿ç¬ç«æ³äººãå»è¬åå»çæ©åšç·åæ©æ§
ã³ãããŠã€ã«ã¹æ žé
žããã
åœå
ã§å
¥æåºæ¥ãæ€æ»æžãããã®æ·»ä»æžé¡ãèŠãããšãã§ããŸãã
https://www.pmda.go.jp/PmdaSearch/ivdDetail/GeneralList/30200EZX00017000_A_01
â¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïžâ¬ïž
ðŽææç ã¯ç·æ¥ãèŠããçºããã25ã®æ€äœã§æ€æ»ããŠãããã«ãããã泚ææžãã«ããã®åŸæ€èšŒãè¡ãããæ瀺ããŠãããããããã¡ãŒã«ãŒããã®ç²ŸåºŠæ€æ»çµæã¯ä»ã®ãšãã0ã§ããããŸã£SARS-CoV2ã¯ã¿ã®ãããªãã ãããã颚éªãã€ã³ãã«ãšã³ã¶ãåããéœæ§ãšãªã£ãŠããããã®äºãå
¬è¡šãã¹ãã§ã¯ãªãã ãããã颚éªãã€ã³ãã«ãšã³ã¶ãç¡æã§æ²»çããŠããããã®ã ãããPCRæ€æ»ãåãã人ã¯å¢ããã¯ãã§ããå
¥é¢ããããæåœãã§ãŸãããã
ðŽéœåžéçºã®ããã«ç¹è¯è¡ã§å·®å¥çPCRæ€æ»ãè¡ãåºãåç£ãããŠäžåœäººã«è²·ãããŠéœåžéçºã
ãããå°æ± çŸååã®ç®çã
æ±äº¬ã§ããé åæ¶å€±ãããããªãããŠããŸãã
蟲家ãåç£ãããŠèŸ²å°ãäžåœãžå£²åŽããå°æ³é²æ¬¡é
æ°Žéæ°å¶åã§åºå€§ãªæµæ°Žå Žäžæ°ŽåŠçå Žãäžåœã«å£²åŽããå°æ³é²æ¬¡é
å°æ± çŸååãšå°æ³é²æ¬¡éã ãã¯ãã·ãããæŽãã§çœ°ããªããŠã¯ãããªãã
ãã®èšäºãæ°ã«å ¥ã£ãããµããŒããããŠã¿ãŸãããïŒ